IND-10009900
type: ClinicalUseDefinition
node role: treeRoot
id:
  v: IND-10009900
meta:
  profile:
    v: http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication
    link: http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication
text:
  status:
    v: generated
  div: Generated Narrative: ClinicalUseDefinition IND-10009900 Profile: CH IDMP ClinicalUseDefinition Indication type: Indication subject: MedicinalProductDefinition: extension = Tablet and solvent for rectal suspension,Distale Form der Colitis ulcerosa bei ungenügendem Ansprechen auf oder Kontraindikation für Mesalazin.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7601001346451-5204201; domain = Human; combinedPharmaceuticalDoseForm = Tablet and solvent for rectal suspension; indication = Leichte bis mittelschwere Colitis ulcerosa des Rectums sowie des Colon sigmoideum.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = budesonide,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product indication DiseaseSymptomProcedures - Concept * Colitis ulcerative IntendedEffects - Concept * therapeutic
type:
  v: indication
subject:
  link: http://fhir.ch/ig/ch-epl/MedicinalProductDefinition/Entocort-Solvent-and-Tablet
  reference:
    v: MedicinalProductDefinition/Entocort-Solvent-and-Tablet

v: 10009900

v: Colitis ulcerative

v: 200000003194

v: therapeutic